A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

Summary

The study evaluates the long-term efficacy and safety of SM-13496 in patients with bipolar I disorder.

Timeline

Start

2014-01-29

Primary completion

2018-02-08

Completion

2018-02-17

Publications

• Higuchi T, Kato T, Miyajima M, Watabe K, Masuda T, Hagi K, Ishigooka J. Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study. Int J Bipolar Disord. 2021 Aug 2;9(1):25. doi: 10.1186/s40345-021-00230-8.
• Ishigooka J, Kato T, Miyajima M, Watabe K, Masuda T, Hagi K, Higuchi T. Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study. J Affect Disord. 2021 Feb 15;281:160-167. doi: 10.1016/j.jad.2020.12.005. Epub 2020 Dec 8.

Drugs

Indications